# Evaluation of Soluble Fibrin in Thrombosis Exclusion

> **NCT02523937** · — · COMPLETED · sponsor: **Diagnostica Stago R&D** · enrollment: 863 (actual)

## Conditions studied

- Pulmonary Embolism (PE)
- Deep Vein Thrombosis (DVT)

## Interventions

- **OTHER:** Soluble Fibrin

## Key facts

- **NCT ID:** NCT02523937
- **Lead sponsor:** Diagnostica Stago R&D
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2018-05
- **Final completion:** 2018-07
- **Target enrollment:** 863 (ACTUAL)
- **Last updated:** 2019-04-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02523937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02523937, "Evaluation of Soluble Fibrin in Thrombosis Exclusion". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02523937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*